ONCS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 1.32%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

OncoSec Medical Insider Trading History Chart

OncoSec Medical Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 06/23/2023 05:00 PM ET

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

OncoSec Medical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/9/2023	Robert J. DelAversano	VP	Sell	40	$1.37	$54.80	1,008
11/4/2022	Robert J. DelAversano	VP	Sell	283	$0.37	$104.71	22,975
8/5/2022	Robert J. DelAversano	VP	Sell	284	$0.71	$201.64	23,258
5/6/2022	Robert J. DelAversano	VP	Sell	274	$0.83	$227.42	23,542
2/9/2022	Robert J. DelAversano	VP	Sell	409	$0.88	$359.92
11/1/2021	Robert J. DelAversano	VP	Sell	343	$1.75	$600.25
8/23/2021	Yuhang Zhao	Director	Buy	4,000	$1.88	$7,520.00	8,000
8/20/2021	Yuhang Zhao	Director	Buy	8,000	$1.94	$15,520.00
8/2/2021	Robert J. Delaversano	VP	Sell	412	$2.18	$898.16	24,568
6/28/2021	Brian A. Leuthner	CEO	Sell	13,613	$3.16	$43,017.08	192,000
5/3/2021	Robert J. DelAversano	VP	Sell	453	$4.86	$2,201.58	24,980
4/30/2021	Daniel J. O'Connor	CEO	Sell	3,172	$4.86	$15,415.92	96,097
4/16/2021	Grand Pharmaceutical & H China	Major Shareholder	Buy	1,691,806	$3.45	$5,836,730.70

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

SEC Filings (Institutional Ownership Changes) for OncoSec Medical (NASDAQ:ONCS)

8.69% of OncoSec Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

OncoSec Medical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/12/2023	FNY Investment Advisers LLC	105,690	$0.27M	0.3%	N/A	3.559%
2/14/2023	Two Sigma Investments LP	21,111	$35K	0.0%	N/A	0.711%
2/13/2023	Renaissance Technologies LLC	24,179	$41K	0.0%	-64.1%	0.814%
2/8/2023	Salzhauer Michael	20,799	$35K	0.0%	-93.0%	0.700%
11/15/2022	Vanguard Group Inc.	717,486	$0.35M	0.0%	-1.9%	40.016%
11/14/2022	Renaissance Technologies LLC	67,398	$33K	0.0%	-7.5%	3.759%
8/13/2022	Renaissance Technologies LLC	72,898	$54K	0.0%	+48.8%	0.185%
5/13/2022	Renaissance Technologies LLC	48,998	$56K	0.0%	-80.4%	0.125%
5/11/2022	Bank of New York Mellon Corp	386,074	$0.44M	0.0%	+653.7%	0.981%
5/10/2022	Salzhauer Michael	296,282	$0.34M	0.2%	-7.8%	0.753%
4/13/2022	Sandbox Financial Partners LLC	27,500	$32K	0.0%	-56.0%	0.070%
2/14/2022	Long Focus Capital Management LLC	69,226	$66K	0.0%	N/A	0.176%
2/4/2022	Salzhauer Michael	321,354	$0.31M	0.1%	+15.9%	0.817%
1/31/2022	D.A. Davidson & CO.	57,500	$55K	0.0%	-47.0%	0.146%
11/16/2021	Schonfeld Strategic Advisors LLC	25,400	$55K	0.0%	-28.0%	0.065%
11/16/2021	Two Sigma Advisers LP	361,401	$0.77M	0.0%	+128.2%	0.922%
11/15/2021	Tocqueville Asset Management L.P.	49,500	$0.11M	0.0%	+86.8%	0.126%
11/15/2021	HighTower Advisors LLC	20,705	$45K	0.0%	N/A	0.053%
9/17/2021	Virtu Financial LLC	12,649	$36K	0.0%	N/A	0.032%
8/17/2021	Boothbay Fund Management LLC	45,370	$0.13M	0.0%	N/A	0.116%
8/17/2021	Caxton Corp	159,935	$0.45M	0.3%	+38.0%	0.408%
8/16/2021	Schonfeld Strategic Advisors LLC	35,300	$99K	0.0%	-15.6%	0.090%
8/16/2021	State Street Corp	19,929	$56K	0.0%	N/A	0.051%
8/16/2021	Shay Capital LLC	25,057	$70K	0.0%	N/A	0.064%
8/16/2021	Tocqueville Asset Management L.P.	26,500	$74K	0.0%	+29.3%	0.068%
8/13/2021	Renaissance Technologies LLC	391,505	$1.10M	0.0%	+14.9%	0.999%
8/13/2021	Jump Financial LLC	20,200	$57K	0.0%	+90.6%	0.052%
8/13/2021	Geode Capital Management LLC	183,322	$0.52M	0.0%	+29.7%	0.468%
8/13/2021	Vanguard Group Inc.	688,263	$1.94M	0.0%	-20.9%	1.756%
8/6/2021	Salzhauer Michael	47,303	$0.13M	0.1%	+26.8%	0.121%
8/5/2021	GSA Capital Partners LLP	29,643	$83K	0.0%	N/A	0.076%
8/4/2021	Envestnet Asset Management Inc.	13,486	$38K	0.0%	N/A	0.034%
5/21/2021	Citadel Advisors LLC	17,903	$86K	0.0%	+38.0%	0.048%
5/19/2021	Squarepoint Ops LLC	52,024	$0.25M	0.0%	N/A	0.140%
5/18/2021	Millennium Management LLC	171,357	$0.82M	0.0%	+184.6%	0.461%
5/18/2021	Citadel Advisors LLC	17,903	$86K	0.0%	+38.0%	0.048%
5/18/2021	Holocene Advisors LP	642,476	$3.07M	0.0%	N/A	1.729%
5/17/2021	Schonfeld Strategic Advisors LLC	41,800	$0.20M	0.0%	-60.6%	0.112%
5/17/2021	HRT Financial LP	15,699	$74K	0.0%	N/A	0.042%
5/13/2021	Renaissance Technologies LLC	340,706	$1.63M	0.0%	+6.8%	0.917%
5/12/2021	Northern Trust Corp	43,358	$0.21M	0.0%	+58.8%	0.117%
5/12/2021	Geode Capital Management LLC	141,335	$0.67M	0.0%	+73.1%	0.380%
5/12/2021	Salzhauer Michael	37,303	$0.18M	0.1%	+36.6%	0.100%
5/6/2021	Sigma Planning Corp	14,502	$69K	0.0%	-55.8%	0.039%
2/16/2021	One68 Global Capital LLC	22,261	$0.14M	0.3%	N/A	0.080%
2/16/2021	Price T Rowe Associates Inc. MD	11,400	$74K	0.0%	-33.2%	0.041%
2/16/2021	Avidity Partners Management LP	1,952,000	$12.59M	0.4%	N/A	6.974%
2/16/2021	ExodusPoint Capital Management LP	18,854	$0.12M	0.0%	N/A	0.067%
2/12/2021	Sandbox Financial Partners LLC	75,000	$0.48M	0.4%	N/A	0.268%
2/11/2021	Northern Trust Corp	27,310	$0.18M	0.0%	+94.9%	0.098%
2/10/2021	Renaissance Technologies LLC	318,906	$2.06M	0.0%	-20.8%	1.139%
2/9/2021	Sigma Planning Corp	32,802	$0.21M	0.0%	-26.0%	0.117%
2/5/2021	BlackRock Inc.	60,526	$0.39M	0.0%	+109.1%	0.216%
1/30/2021	Salzhauer Michael	27,303	$0.18M	0.1%	-15.5%	0.098%
12/11/2020	Virtu Financial LLC	10,167	$34K	0.0%	N/A	0.036%
11/19/2020	Schonfeld Strategic Advisors LLC	27,900	$95K	0.0%	N/A	0.100%
11/17/2020	Schonfeld Strategic Advisors LLC	27,900	$94K	0.0%	N/A	0.101%
11/6/2020	BlackRock Inc.	28,941	$98K	0.0%	-45.7%	0.105%
11/3/2020	Sigma Planning Corp	44,302	$0.15M	0.0%	-8.3%	0.160%
8/10/2020	D.A. Davidson & CO.	118,500	$0.24M	0.0%	+74.9%	0.515%
7/31/2020	Sigma Planning Corp	48,302	$99K	0.0%	+75.6%	0.210%
5/1/2020	Sigma Planning Corp	27,502	$35K	0.0%	N/A	0.121%

Data available starting January 2016

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's product pipeline includes KEYNOTE-695, which is in Phase 2 trial for the treatment of advanced melanoma; TAVO + SARS-CoV-2 spike glycoprotein, which is in Phase 1 clinical trial for the treatment of COVID-19; and TAVO + epacadostat + pembrolizumab, which is in Phase 1 clinical trial for the treatment of squamous cell carcinoma head and neck cancer. Its pipeline also comprises TAVO +nivolumab, which is in Phase 2 clinical trial for the treatment of breast cancer; TAVO + CXCL9 for the treatment of solid tumors; and OMS-100 and OMS-102, which are in Phase 2 clinical trial for the treatment of metastatic melanoma. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890; and a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was incorporated in 2008 and is headquartered in Pennington, New Jersey.

Today's Range

Now: N/A

50 Day Range

MA: $0.52

$0.20

$0.94

52 Week Range

Now: N/A

Volume

52,491,000 shs

Average Volume

2,219,449 shs

Market Capitalization

$1.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.99

Who are the company insiders with the largest holdings of OncoSec Medical?: OncoSec Medical's top insider shareholders include:
Robert J Delaversano (VP)
Learn More about top insider investors at OncoSec Medical.